DK0410246T3 - Erythropoeitin (EPO)-peptider og derimod rettede antistoffer. - Google Patents

Erythropoeitin (EPO)-peptider og derimod rettede antistoffer.

Info

Publication number
DK0410246T3
DK0410246T3 DK90113527T DK90113527T DK0410246T3 DK 0410246 T3 DK0410246 T3 DK 0410246T3 DK 90113527 T DK90113527 T DK 90113527T DK 90113527 T DK90113527 T DK 90113527T DK 0410246 T3 DK0410246 T3 DK 0410246T3
Authority
DK
Denmark
Prior art keywords
epo
antibodies
peptides
epitope
relates
Prior art date
Application number
DK90113527T
Other languages
Danish (da)
English (en)
Inventor
Mathias Dr Fibi
Werner Dr Stueber
Original Assignee
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg Gmbh filed Critical Dade Behring Marburg Gmbh
Application granted granted Critical
Publication of DK0410246T3 publication Critical patent/DK0410246T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90113527T 1989-07-26 1990-07-14 Erythropoeitin (EPO)-peptider og derimod rettede antistoffer. DK0410246T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3924746A DE3924746A1 (de) 1989-07-26 1989-07-26 Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper

Publications (1)

Publication Number Publication Date
DK0410246T3 true DK0410246T3 (da) 1998-08-31

Family

ID=6385895

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90113527T DK0410246T3 (da) 1989-07-26 1990-07-14 Erythropoeitin (EPO)-peptider og derimod rettede antistoffer.

Country Status (13)

Country Link
US (2) US5106954A (fr)
EP (1) EP0410246B1 (fr)
JP (1) JP3155002B2 (fr)
KR (1) KR0175657B1 (fr)
AT (1) ATE161577T1 (fr)
AU (1) AU648506B2 (fr)
CA (1) CA2021912C (fr)
DE (2) DE3924746A1 (fr)
DK (1) DK0410246T3 (fr)
ES (1) ES2111524T3 (fr)
GR (1) GR3026096T3 (fr)
IE (1) IE902707A1 (fr)
PT (1) PT94813B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6932968B1 (en) * 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB2270695B (en) * 1992-09-18 1996-06-05 Oxford Res Support Co Ltd Antibodies that activate plasminogen in the manner of streptokinase
US5830851A (en) * 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
PL185040B1 (pl) * 1995-06-07 2003-02-28 Affymax Tech Nv Peptyd wiążący się z receptorami erytropoetyny, kompozycja farmaceutyczna zawierająca ten peptyd i jego zastosowanie do wytwarzania środka leczniczego
KR100400637B1 (ko) * 1996-02-06 2004-03-10 씨제이 주식회사 생물학적으로유용한펩타이드
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
WO1999028346A1 (fr) * 1997-12-03 1999-06-10 Roche Diagnostics Gmbh Erythropoietine a activite specifique marquee
KR100524041B1 (ko) * 1999-05-07 2005-10-27 제넨테크, 인크. 신규 침팬지 에리쓰로포이에틴 (chepo) 폴리펩티드 및 이를 코딩하는 핵산
EP1177285A1 (fr) * 1999-05-07 2002-02-06 Genentech, Inc. Nouveaux polypeptides d'erythropoietine du chimpanze (chepo) et acides nucleiques codant pour ces memes polypeptides
US6831060B2 (en) 1999-05-07 2004-12-14 Genentech, Inc. Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
US6703480B1 (en) 1999-11-24 2004-03-09 Palani Balu Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
WO2001077677A1 (fr) * 2000-04-05 2001-10-18 Lee Jong Y Détection de l'érythropoïétine et de son récepteur
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
JP2003530838A (ja) 2000-04-12 2003-10-21 ヒューマン ゲノム サイエンシズ インコーポレイテッド アルブミン融合タンパク質
EP1357933A2 (fr) * 2001-02-06 2003-11-05 MERCK PATENT GmbH Erythropoietine (epo) modifiee a immunogenicite reduite
WO2002070009A1 (fr) * 2001-02-27 2002-09-12 Yasuda, Yoshiko Medicaments preventifs/curatifs pour cicatrices hypertrophiques, cheloides et maladies arthritiques chroniques
WO2002097038A2 (fr) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Proteines hybrides beta-1 de chimiokine
ES2261458T3 (es) * 2001-07-26 2006-11-16 Tagra Biotechnologies Ltd Derivados estabilizados del aciddo ascorbico 3-fosfato.
US6930086B2 (en) 2001-09-25 2005-08-16 Hoffmann-La Roche Inc. Diglycosylated erythropoietin
CA2471363C (fr) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Proteines hybrides d'albumine
CA2484556A1 (fr) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Proteines de fusion d'albumine
WO2005003296A2 (fr) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Proteines hybrides d'albumine
BR0313135A (pt) * 2002-08-09 2005-07-05 Merck Patent Gmbh Epìtopos de células t em eritropoietina
EP1608672A4 (fr) * 2003-04-02 2007-11-21 Epimmune Inc Peptides, polypeptides et proteines d'immunogenicite reduite et leurs procedes de production
EP1615945B1 (fr) 2003-04-09 2011-09-28 BioGeneriX AG Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes
US20040266993A1 (en) * 2003-06-30 2004-12-30 Evans Glen A. Non-immunoglobulin binding polypeptides
US7588745B2 (en) * 2004-04-13 2009-09-15 Si Options, Llc Silicon-containing products
US20050255112A1 (en) * 2004-05-17 2005-11-17 Lee Jong Y Compositions and methods for preventing erythropoietin-associated hypertension
WO2009100255A2 (fr) 2008-02-08 2009-08-13 Ambrx, Inc. Polypeptides leptine modifiés et leurs utilisations
AU2005303887A1 (en) * 2004-11-10 2006-05-18 Aplagen Gmbh Molecules which promote hematopoiesis
US7589063B2 (en) * 2004-12-14 2009-09-15 Aplagen Gmbh Molecules which promote hematopoiesis
MX2007005640A (es) * 2004-11-10 2007-08-14 Aplagen Gmbh Moleculas que promueven la hematopoyesis.
WO2006089228A2 (fr) 2005-02-16 2006-08-24 Nektar Therapeutics Al, Corporation Conjugues d'une fraction d'epo et d'un polymere
EP2385061A3 (fr) 2005-05-10 2012-02-22 Neoloch Aps Peptides neuritogènes
EP1736481A1 (fr) * 2005-05-13 2006-12-27 Charite Universitätsmedizin-Berlin Variants d'érythropoietine
EP1907417A2 (fr) * 2005-06-23 2008-04-09 AplaGen GmbH Composes supravalents
UA100222C2 (uk) 2005-08-05 2012-12-10 Араім Фармасьютікалз, Інк. Тканинозахисні пептиди і їх застосування
EP2007791A2 (fr) * 2006-03-09 2008-12-31 AplaGen GmbH Molécules favorisant l'hématopoiese
EP2134862A4 (fr) * 2007-03-12 2011-04-20 Univ Utah Res Found Compositions et procedes pour le diagnostic et le traitement de complications microvasculaires diabetiques
SG10201604530SA (en) 2008-01-22 2016-07-28 Araim Pharmaceuticals Inc Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
PE20110832A1 (es) 2008-09-26 2011-11-24 Ambrx Inc Polipeptidos de eritropoyetina felina modificados
CA2893767C (fr) 2012-12-05 2022-11-08 Novartis Ag Compositions et procedes pour des anticorps ciblant epo
CN107922975B (zh) 2015-08-12 2022-06-28 诺华股份有限公司 治疗眼科病症的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145222A (en) * 1980-04-28 1981-11-11 Toshiyuki Hamaoka Improved antibody and its preparation
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4558005A (en) * 1982-09-13 1985-12-10 University Patents, Inc. Monoclonal anti-erythropoietin
US4558006A (en) * 1983-02-04 1985-12-10 Kirin-Amgen, Inc. A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions

Also Published As

Publication number Publication date
US5712370A (en) 1998-01-27
JPH0381294A (ja) 1991-04-05
DE3924746A1 (de) 1991-01-31
AU5977890A (en) 1991-01-31
US5106954A (en) 1992-04-21
PT94813B (pt) 1997-04-30
AU648506B2 (en) 1994-04-28
ATE161577T1 (de) 1998-01-15
JP3155002B2 (ja) 2001-04-09
ES2111524T3 (es) 1998-03-16
EP0410246A1 (fr) 1991-01-30
KR0175657B1 (ko) 1999-04-01
KR910002897A (ko) 1991-02-26
EP0410246B1 (fr) 1997-12-29
IE902707A1 (en) 1991-02-27
CA2021912A1 (fr) 1991-01-27
CA2021912C (fr) 2001-11-27
PT94813A (pt) 1991-03-20
DE59010787D1 (de) 1998-02-05
GR3026096T3 (en) 1998-05-29

Similar Documents

Publication Publication Date Title
DK0410246T3 (da) Erythropoeitin (EPO)-peptider og derimod rettede antistoffer.
ES2082775T3 (es) Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos.
WO1996029605A3 (fr) Composes et methodes de depistage de l'infection par trypanosoma cruzi
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
SG50681A1 (en) Method for the production of monoclonal antibodies utilizing a germfree animal
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
NO910209L (no) Fremgangsmaate for fremstilling av rekombinante humane anti-cd18-antistoffer.
DE3689948T2 (de) Monoklonale antikörper und testverfahren.
DE68903882D1 (de) Immunochemisches testverfahren fuer humanen granulozyten-makrophagen-kolonie stimulierenden faktor.
DE69228739T2 (de) Immunoassay und monoklonaler antikörper zum nachweis von diarrhetischem schalentiergift
DE3785175T2 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
NO974852L (no) Humant <beta>2-integrin-<alfa>-subenhet
NO974793D0 (no) Fremgangsmåte til fremstilling av et monoklonalt antistoff mot Onkostatin M, eller et fragment derav
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens
RU96119723A (ru) Способ выявления т-зависимого иммунодефицита
ZA903854B (en) Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
NO912192D0 (no) Rekombinante dna og fremgangsmaate for fremstilling av chimere antistoffer.
DK362087D0 (da) Method for a rapid and sensitive detection of early appearing antibodies against retroviruses, as well as igg antibodies against certain retroviruses
NO890775D0 (no) Apparat for testing av utblaasningssikring.
DK27991D0 (da) Telefon med sensorer for human test, og transmitteret isaer via isdn-net
SE8600543D0 (sv) Diagnostiskt test for detektering av antikroppar i kroppsvetskor
DK630189D0 (da) Fremgangsmaade og diagnosesaet til paavisning af antistoffer samt vandig vaskevaeske til brug herved
NO912050D0 (no) Sensor for optisk undersoekelse.